Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,759.04
(
-0.30%
)
News Focus
News Focus
Post# of 257382
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

buckiii2

Send PM Follow Ignore
Followers 59
Posts 4696
Boards Moderated 0
Alias Born 04/27/2009

buckiii2

Re: None

Tuesday, 05/15/2012 9:50:50 AM

Tuesday, May 15, 2012 9:50:50 AM

Post# of 257382
(ILNS) On May 8, 2012, the U.S. Patent and Trademark Office (USPTO) granted our patent covering Intellect's ANTISENILIN monoclonal antibody platform technology for the treatment and prevention of Alzheimer's disease. http://finance.yahoo.com/news/intellect-neurosciences-issues-letter-shareholders-133500865.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today